
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
UDG CRISPR/Cas9 KO Plasmid (h) | sc-403189 | 20 µg | $397.00 |
Human UNG encodes uracil-DNA glycosylase (UDG), a key base excision repair enzyme that initiates removal of uracil from DNA generated by cytosine deamination or misincorporation of dUMP during replication. By excising uracil and creating an abasic site for downstream processing, UNG helps preserve genome stability and limits mutagenesis in both nuclear and mitochondrial genomes. UNG activity interfaces with replication stress responses, DNA damage signaling, and pathways that counteract deamination-driven lesions, including processes relevant to antibody diversification and innate restriction of retroviral DNA. Dysregulation of uracil repair and associated repair intermediates has been linked to elevated mutation burden and genomic instability phenotypes studied across cancer biology, immunology, and host–pathogen interactions.
UDG CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the UNG gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the UNG together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the UNG open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish UDG protein expression.
This CRISPR knockout system enables efficient generation of UNG-deficient cell models for investigation of UDG signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.